Management of metastatic colon cancer requires integration of imaging, disease distribution, molecular features, treatment response, operative risk, and patient preferences. Clinicians outside specialty centers may have limited exposure to evolving criteria for resection, staged or combined operations, conversion strategies, and alternatives such as ablation or radiation. Recognition of the need for specialty or tertiary care may occur late, after treatment decisions have narrowed options or after potentially resectable disease has progressed. 

Clinicians may not consistently recognize which patients with metastatic colon cancer may need surgical or multidisciplinary evaluation. Resectability and treatment sequencing can be complex, particularly when disease involves the liver, lung, peritoneum, or multiple sites, and rapid advances in systemic and local therapies can make older assumptions about “unresectable” disease outdated. Ideal practice includes early multidisciplinary review, evidence-based assessment of disease biology and technical resectability, and coordinated sequencing of surgery, systemic therapy, and other local treatments based on individualized goals of care.